Publication date: Available online 24 April 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Jana P. Lovell, Ladan Foruraghi, Alexandra F. Freeman, Gulbu Uzel, Christa S. Zerbe, Helen Su, Amy P. Hsu, Steven M. Holland
In the absence of acquired or secondary immunosuppression, mutations causing failure to properly activate the IL-12/IFN-γ pathway, NF-κB, or STAT3 should be excluded in patients presenting with severe histoplasmosis.
from #ENT via xlomafota13 on Inoreader http://ift.tt/1MR8NAg
via IFTTT
Κυριακή 24 Απριλίου 2016
Persistent nodal histoplasmosis in NF-κB essential modulator (NEMO) deficiency: Report of a case and review of infection in primary immunodeficiencies
Αναρτήθηκε από
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182
στις
12:22 μ.μ.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου